Key facts:
The healthcare industry is undergoing rapid transformation, with AI leading the charge toward a LIFEcare system that seamlessly integrates prevention and personalized treatment into everyday life. To remain competitive, pharmaceutical companies must innovate their business models to leverage AI-driven opportunities. Success will depend on implementing AI-powered, customer-centric solutions tailored to regional contexts.
This report explores the transformative potential of AI in global healthcare, providing strategic guidance for pharmaceutical and life sciences companies to navigate this evolving landscape. Key insights reveal that the global healthcare market is projected to grow at a 5% CAGR from 2025 to 2030, reaching nearly US$ 30 trillion, with inpatient and outpatient care playing significant roles. By 2030, AI's influence in healthcare will more than double, increasing its market share from 15% to over 30%, with adoption rates varying by region and segment. The AI healthcare market is anticipated to reach US$ 868 billion, generating US$ 646 billion in cost savings and US$ 222 billion in revenue gains.